A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine

Progressive increase in mtDNA 3243A>G heteroplasmy causes abrupt transcriptional reprogramming Wallace hypothesized mitochondrial dysfunction as a central role in a wide range of age-related disorders and various forms of cancer. Steadily rising increases in mitochondrial DNA mutations cause abr

[ read more ]

About metabolism of a carcinoma cell

Most cancer cells utilize aerobic glycolysis irrespective of their tissue of origin. The alteration from oxidative phosphorylation to glycolysis – called the Warburg effect – is an universal phenomen and has now become a diagnostic tool for cancer detection. Warburg O, Posener K, Negelein E.

[ read more ]

A new theory of the origin of cancer: quantum coherent entanglement, centrioles, mitosis, and differentiation

Low non-specific, low intensity laser illumination (635, 670 or 830 nm) apparently enhances centriole replication and promotes cell division, what is the opposite of a desired cancer therapy. In the contrary, centrioles are sensitive to coherent light. Then higher intensity laser illumination - stil

[ read more ]

Quantum Teleportation and Von Neumann Entropy

From the aspect of the quantum information theories, various quantum entropies are possibly computed at each stage, which ensures the emergence of the entangled states in the intermediate step. If a single qubit quantum teleportation is near the computational basis, the quantum measurement is domina

[ read more ]

Mitochondria and the evolutionary roots of cancer

Cancer is a group of almost 200 diseases that involve variety of changes in cell structure, morphology, and physiology. Cancer phenotype is underlying several alterations in cellular dynamics with three most critical features, which includes self-sufficiency in growth signals and insensitivity to in

[ read more ]

Quantum Tunnelling to the Origin and Evolution of Life

Quantum tunnelling is a phenomenon which becomes relevant at the nanoscale and below. It is a paradox from the classical point of view as it enables elementary particles and atoms to permeate an energetic barrier without the need for sufficient energy to overcome it. Tunnelling is being of vital imp

[ read more ]

Wholeness and implicate order: “Deep” quantum chemistry and cell consciousness: quantum chemistry controls genes and biochemistry to give cells and higher organism’s consciousness and complex behavior

Bohm used the term ‘holomovement’ which is an unbroken and undivided totality and carries an implicate order which is he totality of an order including both the manifested and non-manifested aspects of the order. Non-local quantum phenomena reside in a subtler level than quantum level that is th

[ read more ]

Quantum entanglement between the electron clouds of nucleic acids in DNA

Rieper, Anders and Vedral modelled the electron clouds of nucleic acids in a single strand of DNA as a chain of coupled quantum harmonic oscillators with dipole-dipole interaction between nearest neighbours. As a main result, the entanglement contained in the chain coincides with the binding energy

[ read more ]

Implications of quantum metabolism and natural selection for the origin of cancer cells and tumor progression

Energy transfer in material solids is driven primarily by differences in intensive thermodynamic quantities such as pressure and temperature. The crucial observation  in quantum-theoretical models was the consideration of the heat capacity as associated with the vibrations of atoms in a crystalline

[ read more ]

Variation in cancer risk among tissues can be explained by the number of stem cell divisions

Tomasetti and Vogelstein show that the lifetime risk of cancers of many different types is strongly correlated with the total number of divisions of the normal self-renewing cells maintaining that tissue’s homeostasis. These results suggest that only a third of the variation in cancer risk among t

[ read more ]

A global assessment of cancer genomic alterations in epigenetic mechanisms

Muhammad A Shah, Emily L Denton, Cheryl H Arrowsmith, Mathieu Lupien and Matthieu Schapira

Abstract

Background

The notion that epigenetic mechanisms may be central to cancer initiation and progression is supported by recent next-generation sequencing efforts revealing that genes involved in chromatin-mediated signaling are recurrently mutated in cancer patients.

Results

Here, we analyze mutational and transcriptional profiles from TCGA and the ICGC across a collection 441 chromatin factors and histones. Chromatin factors essential for rapid replication are frequently overexpressed, and those that maintain genome stability frequently mutated. We identify novel mutation hotspots such as K36M in histone H3.1, and uncover a general trend in which transcriptional profiles and somatic mutations in tumor samples favor increased transcriptionally repressive histone methylation, and defective chromatin remodeling.

Conclusions

This unbiased approach confirms previously published data, uncovers novel cancer-associated aberrations targeting epigenetic mechanisms, and justifies continued monitoring of chromatin-related alterations as a class, as more cancer types and distinct cancer stages are represented in cancer genomics data repositories.

Continue reading A global assessment of cancer genomic alterations in epigenetic mechanisms

Three-dimensional super-resolution microscopy of the inactive X chromosome territory reveals a collapse of its active nuclear compartment harboring distinct Xist RNA foci

3D-SIM-based DAPI intensity classification in the Barr body versus the entire nucleus of C2C12 cells. (A) Mid z-section of a DAPI-stained nucleus. The area below the dashed line illustrates the resolution level obtained by wide-field deconvolution microscopy, for comparison. Inset magnifications show the non-uniformly compacted structure of the Barr body resolvable with 3D-SIM (1) and an arbitrary autosomal region with CDCs (2). Scale bars: 5 μm, insets 1 μm. (B) X chromosome-specific painting (green) of Xi (left) and Xa territories (right) of the same nucleus in different z-sections. Note the high convergence between the painted Xi and the DAPI visualized Barr body (arrowheads). Scale bars: 2 μm, insets 1 μm. (C) 3D DAPI intensity classification exemplified for the nucleus shown in (A). Seven DAPI intensity classes displayed in false-color code ranging from class 1 (blue) representing pixels close to background intensity, largely representing the IC, up to class 7 (white) representing pixels with highest density, mainly associated with chromocenters. Framed areas of the Barr body (inset 1) and a representative autosomal region (inset 2) are shown on the right at resolution levels of 3D-SIM, deconvolution and conventional wide-field microscopy. The Xi territory pervaded by lower DAPI intensities becomes evident only at 3D-SIM resolution, whereas both wide-field and deconvolution microscopy imply a concentric increase of density in the Barr body. In the autosomal region, chromatin assigned to classes 2 to 3 lines compacted CDCs, represented by classes 4 to 6. (D) Left: average DAPI intensity classification profiles with standard deviations evaluated for entire nuclear volumes or the Barr body region only (dark grey bars). Right: over/underrepresentation of the average DAPI intensity class fraction sizes in the Barr body versus entire nuclear volumes (n = 12). Distribution differences on classes between Xi and entire nucleus P <0.001. 3D-SIM, three-dimensional structured illumination microscopy; CDC, chromatin domain cluster; DAPI, 4',6-diamidino-2-phenylindole; FISH, fluorescence in situ hybridization; IC, interchromatin compartment; Xa, active X chromosome; Xi, inactive X chromosome. Smeets et al. Epigenetics & Chromatin 2014 7:8   doi:10.1186/1756-8935-7-8

3D-SIM-based DAPI intensity classification in the Barr body versus the entire nucleus of C2C12 cells. (A) Mid z-section of a DAPI-stained nucleus. The area below the dashed line illustrates the resolution level obtained by wide-field deconvolution microscopy, for comparison. Inset magnifications show the non-uniformly compacted structure of the Barr body resolvable with 3D-SIM (1) and an arbitrary autosomal region with CDCs (2). Scale bars: 5 μm, insets 1 μm. (B) X chromosome-specific painting (green) of Xi (left) and Xa territories (right) of the same nucleus in different z-sections. Note the high convergence between the painted Xi and the DAPI visualized Barr body (arrowheads). Scale bars: 2 μm, insets 1 μm. (C) 3D DAPI intensity classification exemplified for the nucleus shown in (A). Seven DAPI intensity classes displayed in false-color code ranging from class 1 (blue) representing pixels close to background intensity, largely representing the IC, up to class 7 (white) representing pixels with highest density, mainly associated with chromocenters. Framed areas of the Barr body (inset 1) and a representative autosomal region (inset 2) are shown on the right at resolution levels of 3D-SIM, deconvolution and conventional wide-field microscopy. The Xi territory pervaded by lower DAPI intensities becomes evident only at 3D-SIM resolution, whereas both wide-field and deconvolution microscopy imply a concentric increase of density in the Barr body. In the autosomal region, chromatin assigned to classes 2 to 3 lines compacted CDCs, represented by classes 4 to 6. (D) Left: average DAPI intensity classification profiles with standard deviations evaluated for entire nuclear volumes or the Barr body region only (dark grey bars). Right: over/underrepresentation of the average DAPI intensity class fraction sizes in the Barr body versus entire nuclear volumes (n = 12). Distribution differences on classes between Xi and entire nucleus P Smeets et al. Epigenetics & Chromatin 2014 7:8 doi:10.1186/1756-8935-7-8

Daniel Smeets, Yolanda Markaki, Volker J Schmid, Felix Kraus, Anna Tattermusch, Andrea Cerase, Michael Sterr, Susanne Fiedler, Justin Demmerle, Jens Popken, Heinrich Leonhardt, Neil Brockdorff, Thomas Cremer1, Lothar Schermelleh and Marion Cremer

Abstract

Background

A Xist RNA decorated Barr body is the structural hallmark of the compacted inactive X territory in female mammals. Using super-resolution three-dimensional structured illumination microscopy (3D-SIM) and quantitative image analysis, we compared its ultrastructure with active chromosome territories (CTs) in human and mouse somatic cells, and explored the spatio-temporal process of Barr body formation at onset of inactivation in early differentiating mouse embryonic stem cells (ESCs).

Results

We demonstrate that all CTs are composed of structurally linked chromatin domain clusters (CDCs). In active CTs the periphery of CDCs harbors low-density chromatin enriched with transcriptionally competent markers, called the perichromatin region (PR). The PR borders on a contiguous channel system, the interchromatin compartment (IC), which starts at nuclear pores and pervades CTs. We propose that the PR and macromolecular complexes in IC channels together form the transcriptionally permissive active nuclear compartment (ANC). The Barr body differs from active CTs by a partially collapsed ANC with CDCs coming significantly closer together, although a rudimentary IC channel system connected to nuclear pores is maintained. Distinct Xist RNA foci, closely adjacent to the nuclear matrix scaffold attachment factor-A (SAF-A) localize throughout Xi along the rudimentary ANC. In early differentiating ESCs initial Xist RNA spreading precedes Barr body formation, which occurs concurrent with the subsequent exclusion of RNA polymerase II (RNAP II). Induction of a transgenic autosomal Xist RNA in a male ESC triggers the formation of an ‘autosomal Barr body’ with less compacted chromatin and incomplete RNAP II exclusion.

Conclusions

3D-SIM provides experimental evidence for profound differences between the functional architecture of transcriptionally active CTs and the Barr body. Basic structural features of CT organization such as CDCs and IC channels are however still recognized, arguing against a uniform compaction of the Barr body at the nucleosome level. The localization of distinct Xist RNA foci at boundaries of the rudimentary ANC may be considered as snap-shots of a dynamic interaction with silenced genes. Enrichment of SAF-A within Xi territories and its close spatial association with Xist RNA suggests their cooperative function for structural organization of Xi.

Continue reading Three-dimensional super-resolution microscopy of the inactive X chromosome territory reveals a collapse of its active nuclear compartment harboring distinct Xist RNA foci

The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats

Non-neoplastic histopathological findings in the abdominal cavity. A: High-power view of anti-podoplanin immunohistochemistry showing single MWCNT A (high dose) nanotubes in the tissue (arrows). B: High-power view of anti-podoplanin immunohistochemistry showing single asbestos fibers in the tissue (arrows). C: H & E, high-power view of granuloma induced by MWCNT A (low dose) nanotubes including single nanotube (arrow, 25×). D: H & E, high-power view of granuloma induced by asbestos including single fiber (arrow, 40×). Rittinghausen et al. Particle and Fibre Toxicology 2014 11:59   doi:10.1186/s12989-014-0059-z

Non-neoplastic histopathological findings in the abdominal cavity. A: High-power view of anti-podoplanin immunohistochemistry showing single MWCNT A (high dose) nanotubes in the tissue (arrows). B: High-power view of anti-podoplanin immunohistochemistry showing single asbestos fibers in the tissue (arrows). C: H & E, high-power view of granuloma induced by MWCNT A (low dose) nanotubes including single nanotube (arrow, 25×). D: H & E, high-power view of granuloma induced by asbestos including single fiber (arrow, 40×).
Rittinghausen et al. Particle and Fibre Toxicology 2014 11:59 doi:10.1186/s12989-014-0059-z

Susanne Rittinghausen, Anja Hackbarth, Otto Creutzenberg, Heinrich Ernst, Uwe Heinrich, Albrecht Leonhardt and Dirk Schaudien

Abstract

Background

Biological effects of tailor-made multi-walled carbon nanotubes (MWCNTs) without functionalization were investigated in vivo in a two-year carcinogenicity study. In the past, intraperitoneal carcinogenicity studies in rats using biopersistent granular dusts had always been negative, whereas a number of such studies with different asbestos fibers had shown tumor induction. The aim of this study was to identify possible carcinogenic effects of MWCNTs. We compared induced tumors with asbestos-induced mesotheliomas and evaluated their relevance for humans by immunohistochemical methods.

Methods

A total of 500 male Wistar rats (50 per group) were treated once by intraperitoneal injection with 109 or 5 × 109 WHO carbon nanotubes of one of four different MWCNTs suspended in artificial lung medium, which was also used as negative control. Amosite asbestos (108 WHO fibers) served as positive control. Morbid rats were sacrificed and necropsy comprising all organs was performed. Histopathological classification of tumors and, additionally, immunohistochemistry were conducted for podoplanin, pan-cytokeratin, and vimentin to compare induced tumors with malignant mesotheliomas occurring in humans.

Results

Treatments induced tumors in all dose groups, but incidences and times to tumor differed between groups. Most tumors were histologically and immunohistochemically classified as malignant mesotheliomas, revealing a predominantly superficial spread on the serosal surface of the abdominal cavity. Furthermore, most tumors showed invasion of peritoneal organs, especially the diaphragm. All tested MWCNT types caused mesotheliomas. We observed highest frequencies and earliest appearances after treatment with the rather straight MWCNT types A and B. In the MWCNT C groups, first appearances of morbid mesothelioma-bearing rats were only slightly later. Later during the two-year study, we found mesotheliomas also in rats treated with MWCNT D – the most curved type of nanotubes. Malignant mesotheliomas induced by intraperitoneal injection of different MWCNTs and of asbestos were histopathologically and immunohistochemically similar, also compared with mesotheliomas in man, suggesting similar pathogenesis.

Conclusion

We showed a carcinogenic effect for all tested MWCNTs. Besides aspect ratio, curvature seems to be an important parameter influencing the carcinogenicity of MWCNTs.

Continue reading The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats

Forscher des HIPS und des HZI finden neues Antibiotikum gegen gram-negative Bakterien

Biologinnen untersuchen Bakterien unter dem Mikroskop. Foto: Oliver Dietze

Biologinnen untersuchen Bakterien unter dem Mikroskop. Foto: Universität des Saarlandes, Oliver Dietze

Die Erreger von Infektionserkrankungen Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumanii und Pseudomonas aeruginosa haben zwei große Gemeinsamkeiten: Sie gehören zu den sogenannten gram-negativen Bakterien und sind in Krankenhäusern besonders gefürchtet. Wissenschaftler des Helmholtz-Instituts für Pharmazeutische Forschung Saarland (HIPS) und des Helmholtz-Zentrums für Infektionsforschung (HZI) in Braunschweig haben nun ein potenzielles neues Antibiotikum entdeckt, das gegen diese schwer zu bekämpfenden Bakterien wirkt. Ihre Ergebnisse veröffentlichten die Forscher im renommierten Journal Angewandte Chemie International Edition.

Immer mehr Keime entwickeln Resistenzen gegen Antibiotika, sodass diese einstigen Wunderwaffen ihre Wirkungskraft verlieren. Vor allem in Krankenhäusern stellt die steigende Anzahl resistenter Keime das Personal vor große Probleme und ist eine große Gefahr für die Patienten. „Am schwierigsten zu behandeln ist die Gruppe der gram-negativen Bakterien. Diese besitzen zwei Zellmembranen. Potenzielle Wirkstoffe müssen durch beide hindurch, um eine Wirkung zu erzielen“, sagt Prof. Rolf Müller, Geschäftsführender Direktor des HIPS. Dadurch sind die Anforderungen an mögliche Wirkstoffe wesentlich komplexer als bei den gram-positiven Bakterien, die nur eine Zellmembran besitzen.

Trotz der komplexen Anforderungen ist es Müller und seinen Kollegen aus der Abteilung „Mikrobielle Naturstoffe“ am HIPS und „Mikrobielle Wirkstoffe“ am HZI gelungen, aus dem Myxobakterium Cystobacter sp. einen Stoff zu isolieren, der auch gegen gram-negative Bakterien wirkt. „Wir haben eine aus chemischer Sicht vollkommen neue Stoffklasse entdeckt, die wir Cystobactamide getauft haben“, sagt Müller. „In Experimenten haben wir gezeigt, dass diese gegen die gram-negativen Bakterien Escherichia coli und Acinetobacter baumannii wirksam sind.“ Die Wirkstoffe sind also in der Lage, die doppelte Zellmembran zu durchdringen und die Bakterien so bekämpfen.

Auch wie sie ihre Wirkung entfalten, konnten die Wissenschaftler bereits zeigen. „Wir konnten nachweisen, dass die Cystobactamide als Gyrasehemmer fungieren: Sie verhindern, dass die DNA der Bakterien platzsparend wie ein verdrillter Gartenschlauch verdichtet werden kann“, erläutert Müller. Wird dieser Vorgang gestört, kann die DNA auch nicht mehr korrekt abgelesen werden, und der Stoffwechsel wird entscheidend behindert.

Gyrasehemmer an sich sind nichts Neues. Ganz im Gegenteil: Viele der bisherigen und wirksamsten Antibiotika basieren auf diesem Prinzip. „Allerdings konnten wir erstmals einen Wirkstoff aus Naturstoffen gewinnen, der so funktioniert“, sagt Müller. Das Potenzial der bekannten, chemisch hergestellten Gyrasehemmer ist praktisch ausgeschöpft. Sie können nach jahrzehntelanger Verbesserung nicht weiterentwickelt werden. In der neuen Stoffklasse der Cystobactamide hingegen gibt es noch vielfältige Optimierungsmöglichkeiten. „Wir hoffen, durch chemische Veränderungen vor allem die Wirkung gegen gram-negative Bakterien weiter verstärken und verbreitern zu können“, erklärt Müller. „Sollte uns das gelingen, sind Cystobactamide ein echter Hoffnungsträger im Kampf gegen Krankenhauskeime und andere gram-negative Bakterien.“

Originalpublikation in Angewandte Chemie International Edition:

Baumann, S., Herrmann, J., Raju, R., Steinmetz, H., Mohr, K. I.,
Hüttel, S., Harmrolfs, K., Stadler, M. and Müller, R. (2014):
„Cystobactamids: Myxobacterial Topoisomerase Inhibitors Exhibiting
Potent Antibacterial Activity“. DOI: 10.1002/anie.201409964
<http://onlinelibrary.wiley.com/doi/10.1002/anie.201409964/full>

Schlaganfall-Patient kann dank neuartiger Therapie wieder räumlich sehen

Das Bild zeigt eine Fusions-Diagnostik: Die Probandin trägt eine Bagolini-Brille. Die Therapeutin hält ihr ein Prisma vor ein Auge und misst dabei ihre Fusion, das heißt, sie ermittelt, inwieweit sie in der Lage ist, die Bilder beider Augen zusammenzuführen. Foto: Oliver Dietze

Das Bild zeigt eine Fusions-Diagnostik: Die Probandin trägt eine Bagolini-Brille. Die Therapeutin hält ihr ein Prisma vor ein Auge und misst dabei ihre Fusion, das heißt, sie ermittelt, inwieweit sie in der Lage ist, die Bilder beider Augen zusammenzuführen. Foto: Universität des Saarlandes, Oliver Dietze

Sehstörungen zählen mit zu den häufigsten Folgen eines Schlaganfalls. In seltenen Fällen tritt dabei der Verlust des räumlichen Sehens ein. Die Patienten nehmen die Welt um sich herum nur noch flach wie ein Bild wahr. Sie können keine Entfernungen mehr abschätzen, etwa wenn sie nach einer Tasse greifen oder sich ihnen auf der Straße ein Auto nähert. Diese Störung haben Forscher aus Saarbrücken um Professor Georg Kerkhoff und Anna-Katharina Schaadt mit Kollegen der Charité – Universitätsmedizin Berlin bei einem Patienten genauer untersucht. Sie haben nun erstmals ein wirksames Behandlungskonzept entwickelt und nachgewiesen, welches Hirnareal für diese Sehstörung verantwortlich ist. Die Studie wurde in der renommierten Fachzeitschrift „Neuropsychologia“ veröffentlicht.

Nach einem Schlaganfall kann es zu unterschiedlichen Formen von Sehstörungen kommen. „Diese äußern sich etwa darin, dass die Patienten auf einer Seite blind sind, sodass sie Hindernisse oder Personen auf der Seite übersehen oder Probleme beim Lesen haben“, erklärt Georg Kerkhoff, Professor für Klinische Neuropsychologie der Saar-Uni und Leiter der Neuropsychologischen Universitätsambulanz. Manchmal sind die Folgen aber weitaus gravierender: So hat das Team um Kerkhoff und Schaadt zusammen mit Forscherkollegen um Neurologie-Professor Dr. Stephan Brandt und Dr. Antje Kraft von der Charité in Berlin einen Patienten betreut, bei dem es in Folge eines Schlaganfalls zum Verlust des räumlichen Sehens gekommen war. Zwar konnte er alle Details in seiner Umgebung wahrnehmen, er war allerdings nicht mehr in der Lage, Entfernungen richtig einzuschätzen. „Für ihn war alles flach wie auf einem Gemälde“, erklärt Anna-Katharina Schaadt, Doktorandin bei Kerkhoff und Erstautorin der Studie. „Er bewegte sich daher wie in Zeitlupe und war stets unsicher, wie weit zum Beispiel eine Kaffeetasse auf dem Tisch entfernt ist oder wie schnell sich ein heranfahrendes Auto nähert.“ Wie ein Blinder habe er daher einen langen Stock genutzt, um sich in seiner Umgebung zu orientieren.

In der Neuropsychologischen Hochschulambulanz auf dem Saarbrücker Campus haben die Wissenschaftler um Kerkhoff und Schaadt zunächst die Ursache für diese Störung gesucht. „Wir haben herausgefunden, dass der Patient die Seheindrücke seiner beiden Augen nicht mehr zu einem Gesamtbild verschmelzen konnte“, sagt Schaadt. Fachleute bezeichnen diesen Prozess bei gesunden Menschen als binokulare Fusion. Sie ist wichtig für das dreidimensionale Sehen.

Nach der Diagnose haben die Psychologen im Rahmen einer Therapie über drei Wochen hinweg täglich das räumliche Sehen des Patienten geschult. Dabei kamen drei verschiedene Verfahren zum Einsatz: Mit speziellen optischen Trainingsgeräten (Prismen, Vergenztrainer und Cheiroskop) wurden dem Patienten zwei seitlich leicht versetzte Bilder präsentiert. Diese sollten mit Hilfe sogenannter konvergenter Augenbewegungen zu einem einzigen Bild zusammengesetzt werden. Bei diesem Prozess bewegen sich die Augen gegensinnig zur Nase hin, während die Bilder aber im Blickfeld bleiben. Mit der Zeit „verschmelzen“ die beiden zu einem Bild, das auch räumliche (stereoskopische) Tiefe enthält. „Für den Betroffenen war es so, als ob jemand einen Schalter umgelegt hat. Plötzlich konnte er wieder räumlich sehen, Entfernungen richtig einschätzen und Gegenstände zielsicher greifen“, schildert Schaadt die Eindrücke des Patienten, der mittlerweile wieder seinem Beruf als Jurist nachgehen kann. Auch ein Jahr später in einer Nachuntersuchung konnte der Patient weiterhin räumlich sehen, sodass er laut Kerkhoff als dauerhaft geheilt gilt.

Mit dem Verfahren könnten Therapeuten künftig auch anderen Schlaganfall-Patienten helfen, diese extreme Form der Sehstörung zu behandeln. Zudem sind die Ergebnisse für die Forschung interessant, wie Professor Brandt erläutert: „Sie zeigen, wie spezifisch unser Gehirn organisiert ist. Das geschädigte Areal im sogenannten Parietallappen V6/V6A ist auf 3D-Sehen spezialisiert. Aus Studien an Primaten ist die Hirnregion bereits bekannt. Ihre Funktion beim Menschen ist aber noch nicht hinreichend erforscht.“

Die Studie ist erschienen unter:

Schaadt, A.K., Brandt, S.A., Kraft, A., Kerkhoff, G. Holmes and Horrax
(1919) revisited: Impaired binocular fusion as a cause of “flat
vision” after right parietal brain damage – A case study.
Neuropsychologia (2015), DOI:10.1016/j.neuropsychologia.2015.01.029

 

Cancer news

New CRISPR technique skips over portions of genes that can cause disease

16. Aug. 2018

In a new study in cells, researchers have adapted CRISPR gene-editing technology to cause the cell’s internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building. Such targeted editing could one day be useful for treating genetic diseases caused by mutations in the genome, such as Duchenne’s muscular dystrophy, Huntington’s disease or some cancers. (Mehr in: Cancer News — ScienceDaily)

- Read more

Diagnosing cancer with malaria protein: New method discovered

16. Aug. 2018

Researchers have discovered a method of diagnosing a broad range of cancers at their early stages by utilizing a particular malaria protein, which sticks to cancer cells in blood samples. The researchers hope that this method can be used in cancer screenings in the near future. (Mehr in: Cancer News — ScienceDaily)

- Read more

Retinoic acid may improve immune response against melanoma

16. Aug. 2018

Clinical trial results describe a promising strategy to remove one of melanoma’s most powerful defenses: By adding retinoic acid to standard-of-care treatment, researchers were able to turn off myeloid-derived suppressor cells (MDSCs) that turn off the immune system, leading to more immune system activity directed at melanoma. (Mehr in: Cancer News — ScienceDaily)

- Read more

Trigger, target, trigger: Scientists explore controlled carbon monoxide release

16. Aug. 2018

Scientists have developed flavonoid-based, organic carbon monoxide-releasing molecules that exhibit CO release only when triggered by visible light. Using fluorescence microscopy, the researchers demonstrate targeted CO delivery by the photoCORMs to human lung cancer cells, as well as the ability of the molecules to produce anti-inflammatory effects. (Mehr in: Cancer News — ScienceDaily)

- Read more

Childhood exposure to secondhand smoke may increase risk of adult lung disease death

16. Aug. 2018

A new study suggests that long-term exposure to secondhand smoke during childhood increases the risk of chronic obstructive pulmonary disease (COPD) death in adulthood. (Mehr in: Cancer News — ScienceDaily)

- Read more

PARP inhibitor improves progression-free survival in patients with advanced breast cancers

15. Aug. 2018

In a randomized, Phase III trial, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes. (Mehr in: Cancer News — ScienceDaily)

- Read more

New HIV therapy reduces virus, boosts immunity in drug-resistant patients

15. Aug. 2018

A new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection. Used in combination with existing HIV medications, the drug is a promising strategy for patients who have run out of effective treatment options, the researchers said. (Mehr in: Cancer News — ScienceDaily)

- Read more

The secret behind cell revival revealed

15. Aug. 2018

Scientists identify essential genes for quiescent cells to switch back to dividing mode using fission yeast that may lead to new cancer therapies. (Mehr in: Cancer News — ScienceDaily)

- Read more

Scientists discover chemical which can kill glioblastoma cells

15. Aug. 2018

Aggressive brain tumor cells taken from patients self-destructed after being exposed to a chemical in laboratory tests, researchers have shown. (Mehr in: Cancer News — ScienceDaily)

- Read more

Light-emitting nanoparticles could provide a safer way to image living cells

15. Aug. 2018

A research team has demonstrated how light-emitting nanoparticles can be used to see deep in living tissue. Researchers hope they can be made to attach to specific components of cells to serve in an advanced imaging system that can pinpoint even single cancer cells. (Mehr in: Cancer News — ScienceDaily)

- Read more

A molecular switch may serve as new target point for cancer and diabetes therapies

15. Aug. 2018

If certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A mechanism recently discovered has a crucial influence on such signaling cascades and may be an important key for the future development of therapies against these diseases. (Mehr in: Cancer News — ScienceDaily)

- Read more

Chemicals found in vegetables prevent colon cancer in mice

14. Aug. 2018

Chemicals produced by vegetables such as kale, cabbage and broccoli could help to maintain a healthy gut and prevent colon cancer, a new study shows. (Mehr in: Cancer News — ScienceDaily)

- Read more

Zombie gene protects against cancer — in elephants

14. Aug. 2018

LIF6, a dead gene that came back to life, prevents cancer by killing cells with DNA damage. (Mehr in: Cancer News — ScienceDaily)

- Read more

Potential guidance for gastric cancer treatment

14. Aug. 2018

Researchers have discovered that gastric cancer tissue samples bearing mutation of a specific gene, MUC16, too are associated with higher tumor mutation loads. Also known as tumor mutation burdens, measurement of high genetic mutation rates among cancerous versus healthy tissue has increasingly been shown to correlate with effective response rates to immunotherapy. The knowledge could bode positively for patients with the biomarker present. (Mehr in: Cancer News — ScienceDaily)

- Read more

Cancer-fighting drugs also help plants fight disease

14. Aug. 2018

Cancer-fighting drugs used on humans can help plants fight disease as well. That discovery, by plant pathologists, could help scientists develop new pathways for plants to battle infection. (Mehr in: Cancer News — ScienceDaily)

- Read more

Stress hormone is key factor in failure of immune system to prevent leukemia

14. Aug. 2018

The human stress hormone cortisol has been identified as a key factor when the immune system fails to prevent leukemia taking hold. (Mehr in: Cancer News — ScienceDaily)

- Read more

Cetuximab+RT found to be inferior to standard treatment in HPV+ oropharyngeal cancer

14. Aug. 2018

An interim analysis of data from a randomized clinical trial of patients with human papillomavirus (HPV)-positive oropharyngeal cancer found that treatment with radiation therapy and cetuximab is associated with worse overall and progression-free survival compared to the current standard treatment with radiation and cisplatin. The trial was designed to see if cetuximab with radiation would be less toxic than cisplatin with radiation without compromising survival for patients with the disease. (Mehr in: Cancer News — ScienceDaily)

- Read more

Veranstaltungen

10. TWINCORE Symposium – Frontiers in translational infection research

01. Aug. 2018

Am 31. August 2018 begrüßen wir zum 10. Mal Wissenschaftlerinnen und Wissenschaftler asu der ganzen Welt zum TWINCORE Symposium. Internationale Experten führen durch aktuelle Entwicklungen der translationalen Infektionsforschung.

http://www.twincore.de/twincore/

Nähere Informationen folgen… (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

12th International Conference and Workshop on Biological Barriers

01. Aug. 2018

Biological Barriers is an international scientific event , organized every two years and receiving constantly 200+ registered attendees from all over the world. In the focus of BioBarriers are human cell and tissue models for facilitating clinical translation of new drugs and delivery systems, especially in the context of infectious diseases. Moreover, we will discuss innovative concepts and materials, also capable to overcome non-cellular diffusion barriers such as mucus or bacterial biofilms. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

OSTSEETAG

01. Aug. 2018

Wer Ostsee-Expertenwissen braucht, ist hier richtig: 3. Ostseetag im Stadthafen Rostock! (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

Klinische Bewertung medizinischer Software

01. Aug. 2018

Für jedes Medizinprodukt muss der Hersteller anhand klinischer Daten die Eignung für die vorgesehene Verwendung nachweisen und die klinischen Risiken vor dem Hintergrund des zu erwartenden Nutzens für den Patienten bewerten. Dies ist ein kontinuierlicher Prozess, der sich bis zur klinischen Nachbeobachtung nach dem Inverkehrbringen erstreckt. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

„Blue Biotechnology in the Baltic Sea Region – from Science to Business“

01. Aug. 2018

Es ist uns eine große Freude, Sie zu der internationalen Konferenz „Blue Biotechnology in the Baltic Sea Region – from Science to Business“ einzuladen. Rund 100 Wissenschaftler, Unternehmer und Interessenvertreter aus dem Umfeld der marinen Biotechnologie werden vom 22. bis zum 24. August 2018 neueste Resultate aus Forschung und Entwicklung sowie erfolgreiche ökonomische Umsetzungen präsentieren. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

Sommerkolleg: Chemie, Physik und Materialwissenschaften

01. Jul. 2018

Das Sommerkolleg bietet Interessierten ab 16 Jahren die Möglichkeit einen vertieften Einblick in das Studium der Chemie und Physik sowie der Materialwissenschaften mit Vorlesungen und Praktika zu gewinnen. Es werden Praktika in der Anorganischen Chemie, der Organischen Chemie, in der Physik, Werkstofftechnik und Umformtechnik angeboten, sowie ein Einführungskurs in die Themenfelder Glas-Bindemittel und Kunststoffverarbeitung. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

RVZ Kolloquium: Prof. Michael Rape

01. Jul. 2018

Prof. Michael Rape from UC Berkeley (US) will talk about his research „The other code: roles of ubiquitin in neuronal development and neurodegeneration“ at the Rudolf Virchow Center of the University of Würzburg. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen